Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbamazepine in Inherited Erythromelalgia with NaV1.7 Mutations
NCT02214615Phase 4Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Apr 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carbamazepine in erythromelalgia, sponsored by United States Department of Veterans Affairs. Started Apr 2014; status: completed.
02
Drugs
carbamazepine
03
Conditions
erythromelalgia
Beyond the preview
Go deeper on NCT02214615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02214615.